Biologic Drug Patents Cases in Third Circuit

Browse 1 biologic drug patents cases decided by Third Circuit. AI-powered summaries, holdings, and legal analysis.

1
Cases
1
Defendant Win

Biologic Drug Patents Opinions from Third Circuit (1)

Johnson & Johnson v. Samsung Bioepis Co Ltd

Third Circuit: Biosimilar Renflexis Does Not Infringe Remicade Patents

Third Circuit · 2026-04-14 · Defendant Win · Impact: 75/100

Johnson & Johnson v. Samsung Bioepis Co Ltd, decided by Third Circuit on April 14, 2026, resulted in a defendant win outcome. The Third Circuit affirmed the District Court's grant of summary judgment ...

Frequently Asked Questions

Q: How many biologic drug patents cases has Third Circuit decided?

CaseLawBrief currently tracks 1 biologic drug patents cases from Third Circuit. This number is updated as new opinions are published.

Q: What types of outcomes occur in biologic drug patents cases at Third Circuit?

Outcome breakdown: Defendant Win: 1.

Q: Where can I find plain English summaries of biologic drug patents rulings from Third Circuit?

Each case page on CaseLawBrief includes an AI-generated plain English summary, key holdings, and legal analysis. Click any case above to read its full analysis.

Explore More

All Third Circuit Cases All Biologic Drug Patents Cases All Courts All Topics Search